Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Debate on measures of outcome.
Tugwell P, Knottnerus JA, Wells G, Idzerda L. Tugwell P, et al. Among authors: wells g. J Clin Epidemiol. 2010 Jan;63(1):1. doi: 10.1016/j.jclinepi.2009.11.001. J Clin Epidemiol. 2010. PMID: 19958999 No abstract available.
Endpoints in rheumatoid arthritis.
Tugwell P, Boers M, Baker P, Wells G, Snider J. Tugwell P, et al. Among authors: wells g. J Rheumatol Suppl. 1994 Oct;42:2-8. J Rheumatol Suppl. 1994. PMID: 7823314
Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology.
Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Saurez-Almazor M, Buchbinder R. Wells G, et al. J Rheumatol. 1999 Jan;26(1):217-21. J Rheumatol. 1999. PMID: 9918267 Clinical Trial.
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A. Tugwell P, et al. Among authors: wells g. Arthritis Rheum. 2000 Mar;43(3):506-14. doi: 10.1002/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U. Arthritis Rheum. 2000. PMID: 10728742 Free article. Clinical Trial.
Efficacy and toxicity of old and new disease modifying antirheumatic drugs.
Tugwell P, Welch V, Suarez-Almazor M, Shea B, Wells G. Tugwell P, et al. Among authors: wells g. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i32-5. doi: 10.1136/ard.59.suppl_1.i32. Ann Rheum Dis. 2000. PMID: 11053083 Free PMC article. Review. No abstract available.
1,990 results